BLRCX | GRSRX | BLRCX / GRSRX | |
Total Expense Ratio | 1.95 | 1.34 | 146% |
Annual Report Gross Expense Ratio | 2.36 | 1.34 | 176% |
Fund Existence | 13 years | 11 years | - |
Gain YTD | 6.190 | 8.475 | 73% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 118M | 2.01B | 6% |
Annual Yield % from dividends | 1.59 | 2.29 | 70% |
Returns for 1 year | 8.32 | 8.53 | 98% |
Returns for 3 years | 3.28 | 8.74 | 37% |
Returns for 5 years | 22.66 | 32.80 | 69% |
Returns for 10 years | 11.30 | 41.43 | 27% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
WMGCX | 18.29 | 0.18 | +0.99% |
Macquarie Mid Cap Growth C | |||
GMVIX | 16.74 | 0.15 | +0.90% |
Goldman Sachs Small/Mid Cap Equity Inv | |||
SBQUX | 13.39 | 0.12 | +0.90% |
AmericaFirst Alpha Trends Factor Class U | |||
PHLCX | 12.13 | 0.06 | +0.50% |
PGIM Jennison Health Sciences C | |||
AQGNX | 12.24 | 0.02 | +0.16% |
AQR Global Equity N |